Pablo Fuentes-Prior

Dr. Pablo Fuentes-Prior


Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 February 2017 in Nature Communications
Verified
Journal Article
Open access
PDF file
MNMarta Nadal
Marta Nadal
Stefan PrekovicStefan Prekovic
Stefan Prekovic
NGNerea Gallastegui
Nerea Gallastegui
CHChristine Helsen
Christine Helsen
MAMontserrat Abella
Montserrat Abella
Eva Estebanez-PerpinaEva Estebanez-Perpina
Eva Estebanez-Perpina
The androgen receptor (AR) plays a crucial role in normal physiology, development and metabolism as well as in the aetiology and treatment of diverse pathologies such as androgen insensitivity syndromes (AIS), male infertility and prostate cancer (PCa). Here we show that dimerization of AR ligand-binding domain (LBD) is induced by receptor agonists but not by antagonists. The 2.15-Å crystal structure of homodimeric, agonist- and coactivator peptide-bound AR-LBD unveils a 1,000-Å2 large dimerization surface, which harbours over 40 previously unexplained AIS- and PCa-associated point mutations. An AIS mutation in the self-association interface (P767A) disrupts dimer formation in vivo, and has a detrimental effect on the transactivating properties of full-length AR, despite retained hormone-binding capacity. The conservation of essential residues suggests that the unveiled dimerization mechanism might be shared by other nuclear receptors. Our work defines AR-LBD homodimerization as an essential step in the proper functioning of this important transcription factor.

1 January 2021 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
PFPablo Fuentes-Prior
Pablo Fuentes-Prior
The ongoing COVID-19 pandemic has already caused over a million deaths worldwide, and this death toll will be much higher before effective treatments and vaccines are available. The causative agent of the disease, the coronavirus SARS-CoV-2, shows important similarities with the previously emerged SARS-CoV-1, but also striking differences. First, SARS-CoV-2 possesses a significantly higher transmission rate and infectivity than SARS-CoV-1 and has infected in a few months over 60 million people. Moreover, COVID-19 has a systemic character, as in addition to the lungs, it also affects the heart, liver, and kidneys among other organs of the patients and causes frequent thrombotic and neurological complications. In fact, the term "viral sepsis" has been recently coined to describe the clinical observations. Here I review current structure–function information on the viral spike proteins and the membrane fusion process to provide plausible explanations for these observations. I hypothesize that several membrane-associated serine proteinases (MASPs), in synergy with or in place of TMPRSS2, contribute to activate the SARS-CoV-2 spike protein. Relative concentrations of the attachment receptor, ACE2, MASPs, their endogenous inhibitors (the Kunitz-type transmembrane inhibitors, HAI-1/SPINT1 and HAI-2/SPINT2, as well as major circulating serpins) would determine the infection rate of host cells. The exclusive or predominant expression of major MASPs in specific human organs suggests a direct role of these proteinases in e.g., heart infection and myocardial injury, liver dysfunction, kidney damage, as well as neurological complications. Thorough consideration of these factors could have a positive impact on the control of the current COVID-19 pandemic.

25 March 2022 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PKPrasanna Kandel
Prasanna Kandel
FSFatih Semerci
Fatih Semerci
RMRachana Mishra
Rachana Mishra
WCWilliam Choi
William Choi
ABAleksandar Bajic
Aleksandar Bajic
MMMirjana Maletic-Savatic
Mirjana Maletic-Savatic
Significance: Adult hippocampal neurogenesis underpins learning, memory, and mood but diminishes with age and certain illnesses. The orphan nuclear receptor TLX/NR2E1 regulates neural stem and progenitor cell self-renewal and proliferation, but its orphan status has hindered its utilization as a therapeutic target to modulate adult neurogenesis. Here, we deorphanize TLX and report that oleic acid is an endogenous, metabolic ligand of TLX. These findings open avenues for future therapeutic modulation of TLX to counteract cognitive and mental decline in aging and diseases associated with decreased neurogenesis.

22 November 2018 in eLife
Verified
Journal Article
Open access
DRDavid Ramos-Vicente
David Ramos-Vicente
JJJie Ji
Jie Ji
EGEsther Gratacòs-Batlle
Esther Gratacòs-Batlle
GGGemma Gou
Gemma Gou
RRRita Reig-Viader
Rita Reig-Viader
ÀBÀlex Bayés
Àlex Bayés
Glutamate receptors are divided in two unrelated families: ionotropic (iGluR), driving synaptic transmission, and metabotropic (mGluR), which modulate synaptic strength. The present classification of GluRs is based on vertebrate proteins and has remained unchanged for over two decades. Here we report an exhaustive phylogenetic study of GluRs in metazoans. Importantly, we demonstrate that GluRs have followed different evolutionary histories in separated animal lineages. Our analysis reveals that the present organization of iGluRs into six classes does not capture the full complexity of their evolution. Instead, we propose an organization into four subfamilies and ten classes, four of which have never been previously described. Furthermore, we report a sister class to mGluR classes I-III, class IV. We show that many unreported proteins are expressed in the nervous system, and that new Epsilon receptors form functional ligand-gated ion channels. We propose an updated classification of glutamate receptors that includes our findings.

1 March 2013 in Journal of Lipid Research
Verified
Journal Article
Open access
PDF file
EBElena de Mendoza Barberá
Elena de Mendoza Barberá
Josep JulveJosep Julve
Josep Julve
SNStefan K. Nilsson
Stefan K. Nilsson
ALAivar Lookene
Aivar Lookene
JCJesús Maria Martín- Campos
Jesús Maria Martín- Campos
FBFrancisco Blanco-Vaca
Francisco Blanco-Vaca
During the diagnosis of three unrelated patients with severe hypertriglyceridemia, three APOA5 mutations [p.(Ser232_Leu235)del, p.Leu253Pro, and p.Asp332ValfsX4] were found without evidence of concomitant LPL, APOC2, or GPIHBP1 mutations. The molecular mechanisms by which APOA5 mutations result in severe hypertriglyceridemia remain poorly understood, and the functional impairment/s induced by these specific mutations was not obvious. Therefore, we performed a thorough structural and functional analysis that included follow-up of patients and their closest relatives, measurement of apoA-V serum concentrations, and sequencing of the APOA5 gene in 200 nonhyperlipidemic controls. Further, we cloned, overexpressed, and purified both wild-type and mutant apoA-V variants and characterized their capacity to activate LPL. The interactions of recombinant wild-type and mutated apoA-V variants with liposomes of different composition, heparin, LRP1, sortilin, and SorLA/LR11 were also analyzed. Finally, to explore the possible structural consequences of these mutations, we developed a three-dimensional model of full-length, lipid-free human apoA-V. A complex, wide array of impairments was found in each of the three mutants, suggesting that the specific residues affected are critical structural determinants for apoA-V function in lipoprotein metabolism and, therefore, that these APOA5 mutations are a direct cause of hypertriglyceridemia.

19 March 2021 in Human Mutation
Verified
Journal Article
Open access
PDF file
LBLaura Blasco‐Pérez
Laura Blasco‐Pérez
IPIda Paramonov
Ida Paramonov
JLJordi Leno
Jordi Leno
SBSara Bernal
Sara Bernal
LALaura Alías Andreu
Laura Alías Andreu
ETEduardo Tizzano
Eduardo Tizzano
Spinal muscular atrophy (SMA) is caused by bi‐allelic loss or pathogenic variants in the SMN1 gene. SMN2, the highly homologous copy of SMN1, is considered the major phenotypic modifier of the disease. Determination of SMN2 copy number is essential to establish robust genotype‐phenotype correlations and predict disease evolution, to stratify patients for clinical trials, as well as to define those eligible for treatment. Discordant genotype‐phenotype correlations are not uncommon in SMA, some of which are due to intragenic SMN2 variants that may influence the amount of complete SMN transcripts and therefore of full‐length SMN protein. Detection of these variants is crucial to predict SMA phenotypes in the present scenario of therapeutic advances, and with the perspective of SMA neonatal screening and early diagnosis to start treatments. Here we present a novel, affordable and versatile method for complete sequencing of the SMN2 gene based on long‐range PCR and next‐generation sequencing. The method was validated by analyzing samples from 53 SMA patients who lack SMN1, allowing characterize paralogous, rare variants and SNPs of SMN2 as well as SMN2‐SMN1 hybrid genes. The method identifies partial deletions, and can be adapted to determine rare pathogenic variants in patients with at least one SMN1 copy.